Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 9,851 | 6,537 | 42 | 6,362 | 6,771 |
| Gross Profit | 9,851 | 6,537 | 42 | 6,362 | 6,771 |
| Operating Expenses | 60,812 | 69,983 | 57,562 | 60,596 | 57,521 |
| Operating Income | -50,961 | -63,446 | -57,520 | -54,234 | -50,750 |
| Interest Expense | 1,584 | 0 | -1 | -235 | 234 |
| Other Income | 3,509 | 2,708 | 1,793 | 546 | 469 |
| Pre-tax Income | -49,036 | -60,738 | -55,726 | -53,453 | -50,515 |
| Net Income Continuous | -49,036 | -60,738 | -55,726 | -53,453 | -50,515 |
| Net Income | $-49,036 | $-60,738 | $-55,726 | $-53,453 | $-50,515 |
| EPS Basic Total Ops | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 |
| EPS Basic Continuous Ops | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 |
| EPS Diluted Total Ops | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 |
| EPS Diluted Continuous Ops | -0.71 | -0.88 | -0.81 | -0.78 | -0.74 |
| EBITDA(a) | $-50,110 | $-62,367 | $-56,142 | $-52,636 | $-49,192 |